NOELLE MUTER: Open Payments
NPI 1457124281 · ASHWAUBENON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 60 payments from 14 companies in 2025. Trend: 2023 $133 · 2024 $650 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $218 |
| Supernus Pharmaceuticals, Inc. | 21 | $166 |
| Alkermes, Inc. | 3 | $144 |
| Teva Pharmaceuticals USA, Inc. | 5 | $141 |
| Vanda Pharmaceuticals Inc. | 5 | $115 |
| Otsuka America Pharmaceutical, Inc. | 5 | $106 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Corium, LLC | 2 | $37 |
| Neurocrine BioSciences, Inc. | 2 | $31 |
Products named: VRAYLAR, Qelbree, LYBALVI, AUSTEDO XR, FANAPT, REXULTI, CAPLYTA, Jornay PM.
Industry payments across WI — which companies pay providers there.
